(Q40754066)
Statements
1 reference
A regimen of surgical adjuvant immunotherapy for cancer with interleukin 2 and lymphokine-activated killer cells. Basis, clinical toxicity, and immunomodulatory effects (English)
1 reference
Yano T
1 reference
Ishida T
1 reference
Yoshino I
1 reference
Murata M
1 reference
Yasumoto K
1 reference
Kimura G
1 reference
Nomoto K
1 reference
Sugimachi K
1 reference
1 January 1991
1 reference
1 reference
3
1 reference
3
1 reference
245-251
1 reference
Identifiers
1 reference
1 reference